Trial intelligence / Profile preview

Randomized open-label fasting bioequivalence study of norfloxacin capsule versus norfloxacin tablet in healthy adults

CTR20251784Phase 2Completed

Sponsor
Lukang Saite
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of norfloxacin in urinary tract infection (UTI), gonorrhea, prostatitis, Enteric diseases, typhoid fever, sponsored by Lukang Saite. Started May 2025; status: completed.

02

Drugs

norfloxacin
03

Conditions

urinary tract infection (UTI)gonorrheaprostatitisEnteric diseasestyphoid fever

Beyond the preview

Go deeper on CTR20251784.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20251784.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call